Literature DB >> 18539968

Cancer stem cells and the ontogeny of lung cancer.

Craig D Peacock1, D Neil Watkins.   

Abstract

Lung cancer is the leading cause of cancer death in the world today and is poised to claim approximately 1 billion lives during the 21st century. A major challenge in treating this and other cancers is the intrinsic resistance to conventional therapies demonstrated by the stem/progenitor cell that is responsible for the sustained growth, survival, and invasion of the tumor. Identifying these stem cells in lung cancer and defining the biologic processes necessary for their existence is paramount in developing new clinical approaches with the goal of preventing disease recurrence. This review summarizes our understanding of the cellular and molecular mechanisms operating within the putative cancer-initiating cell at the core of lung neoplasia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18539968      PMCID: PMC3707499          DOI: 10.1200/JCO.2007.15.2702

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  78 in total

1.  Ligand-dependent activation of the hedgehog pathway in glioma progenitor cells.

Authors:  M Ehtesham; A Sarangi; J G Valadez; S Chanthaphaychith; M W Becher; T W Abel; R C Thompson; M K Cooper
Journal:  Oncogene       Date:  2007-03-12       Impact factor: 9.867

2.  Valproic acid activates notch-1 signaling and regulates the neuroendocrine phenotype in carcinoid cancer cells.

Authors:  David Yu Greenblatt; Abram M Vaccaro; Renata Jaskula-Sztul; Li Ning; Megan Haymart; Muthusamy Kunnimalaiyaan; Herbert Chen
Journal:  Oncologist       Date:  2007-08

3.  Gamma-secretase inhibitor prevents Notch3 activation and reduces proliferation in human lung cancers.

Authors:  Jun Konishi; Keiko S Kawaguchi; Huan Vo; Nobuhiro Haruki; Adriana Gonzalez; David P Carbone; Thao P Dang
Journal:  Cancer Res       Date:  2007-09-01       Impact factor: 12.701

Review 4.  INK4 proteins, a family of mammalian CDK inhibitors with novel biological functions.

Authors:  Eduardo T Cánepa; María E Scassa; Julieta M Ceruti; Mariela C Marazita; Abel L Carcagno; Pablo F Sirkin; María F Ogara
Journal:  IUBMB Life       Date:  2007-07       Impact factor: 3.885

5.  Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells.

Authors:  Maria M Ho; Alvin V Ng; Stephen Lam; Jaclyn Y Hung
Journal:  Cancer Res       Date:  2007-05-15       Impact factor: 12.701

6.  Pten controls lung morphogenesis, bronchioalveolar stem cells, and onset of lung adenocarcinomas in mice.

Authors:  Shigehisa Yanagi; Hiroyuki Kishimoto; Kohichi Kawahara; Takehiko Sasaki; Masato Sasaki; Miki Nishio; Nobuyuki Yajima; Koichi Hamada; Yasuo Horie; Hiroshi Kubo; Jeffrey A Whitsett; Tak Wah Mak; Toru Nakano; Masamitsu Nakazato; Akira Suzuki
Journal:  J Clin Invest       Date:  2007-10       Impact factor: 14.808

7.  Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like cancer cells in glioblastoma.

Authors:  Eli E Bar; Aneeka Chaudhry; Alex Lin; Xing Fan; Karisa Schreck; William Matsui; Sara Piccirillo; Angelo L Vescovi; Francesco DiMeco; Alessandro Olivi; Charles G Eberhart
Journal:  Stem Cells       Date:  2007-07-12       Impact factor: 6.277

Review 8.  The pathways to tumor suppression via route p38.

Authors:  Jiahuai Han; Peiqing Sun
Journal:  Trends Biochem Sci       Date:  2007-07-10       Impact factor: 13.807

9.  Discovery of an oncogenic activity in p27Kip1 that causes stem cell expansion and a multiple tumor phenotype.

Authors:  Arnaud Besson; Harry C Hwang; Samantha Cicero; Stacy L Donovan; Mark Gurian-West; Dianna Johnson; Bruce E Clurman; Michael A Dyer; James M Roberts
Journal:  Genes Dev       Date:  2007-07-12       Impact factor: 11.361

10.  p38alpha MAP kinase is essential in lung stem and progenitor cell proliferation and differentiation.

Authors:  Juan José Ventura; Stephan Tenbaum; Eusebio Perdiguero; Marion Huth; Carmen Guerra; Mariano Barbacid; Manolis Pasparakis; Angel R Nebreda
Journal:  Nat Genet       Date:  2007-04-29       Impact factor: 38.330

View more
  45 in total

Review 1.  EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer.

Authors:  A Singh; J Settleman
Journal:  Oncogene       Date:  2010-06-07       Impact factor: 9.867

Review 2.  Chemotherapy and signaling: How can targeted therapies supercharge cytotoxic agents?

Authors:  Tetyana V Bagnyukova; Ilya G Serebriiskii; Yan Zhou; Elizabeth A Hopper-Borge; Erica A Golemis; Igor Astsaturov
Journal:  Cancer Biol Ther       Date:  2010-11-01       Impact factor: 4.742

3.  Permanently blocked stem cells derived from breast cancer cell lines.

Authors:  Gangadharan B Sajithlal; Kristi Rothermund; Fang Zhang; David J Dabbs; Jean J Latimer; Stephen G Grant; Edward V Prochownik
Journal:  Stem Cells       Date:  2010-06       Impact factor: 6.277

Review 4.  Galectin-3 and cancer stemness.

Authors:  Pratima Nangia-Makker; Victor Hogan; Avraham Raz
Journal:  Glycobiology       Date:  2018-04-01       Impact factor: 4.313

5.  Welding and lung cancer in a pooled analysis of case-control studies.

Authors:  Benjamin Kendzia; Thomas Behrens; Karl-Heinz Jöckel; Jack Siemiatycki; Hans Kromhout; Roel Vermeulen; Susan Peters; Rainer Van Gelder; Ann Olsson; Irene Brüske; H-Erich Wichmann; Isabelle Stücker; Florence Guida; Adonina Tardón; Franco Merletti; Dario Mirabelli; Lorenzo Richiardi; Hermann Pohlabeln; Wolfgang Ahrens; Maria Teresa Landi; Neil Caporaso; Dario Consonni; David Zaridze; Neonila Szeszenia-Dabrowska; Jolanta Lissowska; Per Gustavsson; Michael Marcus; Eleonora Fabianova; Andrea 't Mannetje; Neil Pearce; Lap Ah Tse; Ignatius Tak-Sun Yu; Peter Rudnai; Vladimir Bencko; Vladimir Janout; Dana Mates; Lenka Foretova; Francesco Forastiere; John McLaughlin; Paul Demers; Bas Bueno-de-Mesquita; Paolo Boffetta; Joachim Schüz; Kurt Straif; Beate Pesch; Thomas Brüning
Journal:  Am J Epidemiol       Date:  2013-09-19       Impact factor: 4.897

6.  Vismodegib or cixutumumab in combination with standard chemotherapy for patients with extensive-stage small cell lung cancer: A trial of the ECOG-ACRIN Cancer Research Group (E1508).

Authors:  Chandra P Belani; Suzanne E Dahlberg; Charles M Rudin; Martin Fleisher; Helen X Chen; Naoko Takebe; Mario R Velasco; William J Tester; Keren Sturtz; Christine L Hann; James C Shanks; Manish Monga; Suresh S Ramalingam; Joan H Schiller
Journal:  Cancer       Date:  2016-05-10       Impact factor: 6.860

Review 7.  Lung cancer stem cells: progress and prospects.

Authors:  Amber Lundin; Barbara Driscoll
Journal:  Cancer Lett       Date:  2012-08-17       Impact factor: 8.679

8.  Rapid selection and proliferation of CD133+ cells from cancer cell lines: chemotherapeutic implications.

Authors:  Sarah E Kelly; Altomare Di Benedetto; Adelaide Greco; Candace M Howard; Vincent E Sollars; Donald A Primerano; Jagan V Valluri; Pier Paolo Claudio
Journal:  PLoS One       Date:  2010-04-08       Impact factor: 3.240

9.  Regulation of lung cancer metastasis by Klf4-Numb-like signaling.

Authors:  Valentina Vaira; Alice Faversani; Nina M Martin; David S Garlick; Stefano Ferrero; Mario Nosotti; Joseph L Kissil; Silvano Bosari; Dario C Altieri
Journal:  Cancer Res       Date:  2013-02-25       Impact factor: 12.701

10.  The controversial clinicobiological role of breast cancer stem cells.

Authors:  Claudia Casarsa; Saro Oriana; Danila Coradini
Journal:  J Oncol       Date:  2009-03-19       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.